Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
Yingyi Li(Baoji City Central Hospital), Chengqiang Li(Ruijin Hospital), Yuqin Cao(Shanghai Jiao Tong University), Liqin Zhao(Shanghai Medical College of Fudan University), Xipeng Wang(Shanghai Jiao Tong University)
Cited by 0
Related Papers
Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
|Frontiers in Immunology|2018|156
Immunogenic Cell Death-Based Cancer Vaccines
|Frontiers in Immunology|2021|95
Ovarian cancer: epigenetics, drug resistance, and progression
|Cancer Cell International|2021|91
A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study
|Alzheimer s & Dementia|2022|87
COX-2-PGE2-EPs in gynecological cancers
|Archives of Gynecology and Obstetrics|2020|82